至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

J. Biol. Chem.. 2019; 
XiGang,ShenXinchun,WaiChristine,WhiteMorris F,ClemmonsDav
Products/Services Used Details Operation
Peptide Synthesis The synthetic peptides containing YARAAARQARATFSDLWKLLP MDM2/p53 disrupting (a peptide), YARAAARQARAKSKKGQSTSRHKKL (a p53/IRS-1 disrupting peptide), YARAAARQARALSPDDIEQWFTE (a p53/KLF4 disrupting peptide) and YARAAARQARAKALRKHQGAKTAHR (a control peptide) were synthesized by Genscript. Get A Quote

摘要

Hyperglycemia and insulin resistance accelerate atherosclerosis by an unclear mechanism. The two factors down-regulate insulin receptor substrate-1 (IRS-1), an intermediary of the insulin/IGF-I signaling system. We previously reported that IRS-1 down-regulation leads to vascular smooth muscle cell (VSMC) dedifferentiation and that IRS-1 deletion from VSMCs in normoglycemic mice replicates this response. However, we did not determine IRS-1's role in mediating differentiation. Here, we sought to define the mechanism by which IRS-1 maintains VSMC differentiation. High glucose or IRS-1 knockdown decreased p53 levels by enhancing MDM2 proto-oncogene (MDM2)-mediated ubiquitination, resulting in decreased bind... More

关键词

Kruppel-like factor 4 (KLF4),atherosclerosis,cardiovascular disease,inflammation,insulin receptor substrate 1 (IRS-1),insulin resistance,metabolic regulation,myocardin,p53,smooth mu